• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2500035 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products(原15) Supplementary Application 2025-01-27 Tonrol Bio-Pharmaceutical Co Limited view
CYSB2500033 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products(原15) Supplementary Application 2025-01-27 Tonrol Bio-Pharmaceutical Co Limited view
CYSB2500034 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products(原15) Supplementary Application 2025-01-27 Tonrol Bio-Pharmaceutical Co Limited view
CXSS2400108 人纤维蛋白原 Human fibrinogen Lyophilized Biological Products(3.4) New Drug Application 2024-10-09 Tonrol Bio-Pharmaceutical Co Limited view
CXSL2200513 人纤维蛋白原 Human fibrinogen Lyophilized Biological Products(3.4) New Drug Application 2022-10-13 Tonrol Bio-Pharmaceutical Co Limited view
CXSL2200514 人纤维蛋白原 Human fibrinogen Lyophilized Biological Products(3.4) New Drug Application 2022-10-13 Tonrol Bio-Pharmaceutical Co Limited view
CYSB2100038 人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-01-23 同路生物制药有限公司 Tonrol Bio-Pharmaceutical Co Limited Certificate Issued 2021-08-19 view
CYSB2100039 人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-01-23 同路生物制药有限公司 Tonrol Bio-Pharmaceutical Co Limited Certificate Issued 2021-08-19 view
CYSB2000367 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2020-12-18 同路生物制药有限公司 Tonrol Bio-Pharmaceutical Co Limited In Review 2020-12-17 view
CYSB2000366 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2020-12-18 同路生物制药有限公司 Tonrol Bio-Pharmaceutical Co Limited Certificate Issued 2021-09-02 view
CYSB2000365 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2020-12-18 同路生物制药有限公司 Tonrol Bio-Pharmaceutical Co Limited In Review 2020-12-17 view
CYSB2000369 冻干静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Lyophilized Biological Products Supplementary Application 2020-12-18 同路生物制药有限公司 Tonrol Bio-Pharmaceutical Co Limited Certificate Issued 2021-08-06 view
CYSB2000364 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2020-12-18 同路生物制药有限公司 Tonrol Bio-Pharmaceutical Co Limited Certificate Issued 2021-08-27 view
CYSB2000368 冻干静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Lyophilized Biological Products Supplementary Application 2020-12-18 同路生物制药有限公司 Tonrol Bio-Pharmaceutical Co Limited In Review 2020-12-17 view
CYSB2000363 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2020-12-18 同路生物制药有限公司 Tonrol Bio-Pharmaceutical Co Limited In Review 2020-12-17 view
CXSS2000037 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(15) New Drug Application 2020-07-04 同路生物制药有限公司 Tonrol Bio-Pharmaceutical Co Limited Certificate Issued 2021-07-13 view
CYSB1900431 人血白蛋白 human albumin Injection Biological Products Supplementary Application 2020-01-03 同路生物制药有限公司 Tonrol Bio-Pharmaceutical Co Limited Certificate Issued 2021-01-08 view
CYSB1900432 人血白蛋白 human albumin Injection Biological Products Supplementary Application 2020-01-03 同路生物制药有限公司 Tonrol Bio-Pharmaceutical Co Limited Certificate Issued 2021-01-08 view
CXSS1900045 冻干静注乙型肝炎人免疫球蛋白(pH4) human hepatitis B immunoglobulin(pH4) Lyophilized Biological Products(15) New Drug Application 2019-12-11 同路生物制药有限公司 Tonrol Bio-Pharmaceutical Co Limited Certificate Issued 2021-08-04 view
CYSB1800221 人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2018-10-25 同路生物制药有限公司 Tonrol Bio-Pharmaceutical Co Limited Certificate Issued 2019-09-30 view